FDXACB1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.094000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.886800E-01
Normal-vs-Stage2
6.438300E-02
Normal-vs-Stage3
1.368610E-01
Normal-vs-Stage4
4.461200E-01
Stage1-vs-Stage2
6.159800E-01
Stage1-vs-Stage3
8.245800E-02
Stage1-vs-Stage4
9.252800E-01
Stage2-vs-Stage3
1.738630E-01
Stage2-vs-Stage4
7.681800E-01
Stage3-vs-Stage4
3.195600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.888400E-02
Normal-vs-AfricanAmerican
4.787400E-01
Normal-vs-Asian
2.731600E-01
Caucasian-vs-AfricanAmerican
6.076000E-01
Caucasian-vs-Asian
4.364200E-01
AfricanAmerican-vs-Asian
9.453000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.414200E-02
Normal-vs-Female
1.100560E-01
Male-vs-Female
9.751800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.811800E-01
Normal-vs-Age(41-60Yrs)
8.634100E-02
Normal-vs-Age(61-80Yrs)
6.547600E-02
Normal-vs-Age(81-100Yrs)
5.218200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.303200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.668600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.913220E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.144600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.952800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.482800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.512400E-02
Normal-vs-Daily Drinker
1.333380E-01
Normal-vs-Weekly Drinker
3.110400E-01
Normal-vs-Occasional Drinker
4.260000E-01
Normal-vs-Social Drinker
4.357000E-01
Non Drinker-vs-Daily Drinker
7.012400E-01
Non Drinker-vs-Weekly Drinker
1.307580E-01
Non Drinker-vs-Occasional Drinker
2.878400E-01
Non Drinker-vs-Social Drinker
2.749600E-01
Daily Drinker-vs-Weekly Drinker
3.514200E-01
Daily Drinker-vs-Occasional Drinker
6.207600E-01
Daily Drinker-vs-Social Drinker
5.944400E-01
Weekly Drinker-vs-Occasional Drinker
5.294800E-01
Weekly Drinker-vs-Social Drinker
5.947600E-01
Occasional Drinker-vs-Social Drinker
9.293000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.411200E-01
Normal-vs-Grade 2
8.985600E-02
Normal-vs-Grade 3
6.344500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.478100E-02
Grade 1-vs-Grade 3
4.390000E-02
Grade 1-vs-Grade 4
2.411200E-01
Grade 2-vs-Grade 3
9.282800E-01
Grade 2-vs-Grade 4
8.985600E-02
Grade 3-vs-Grade 4
6.344500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.456010E-01
Normal-vs-NonDiabetic
3.826000E-01
Diabetic-vs-NonDiabetic
9.002600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.777240E-01
Normal-vs-NoPancreatitis
5.637500E-02
Pancreatitis-vs-NoPancreatitis
8.374800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.692300E-02
Normal-vs-N1
6.987700E-02
N0-vs-N1
9.636000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.280400E-01
Normal-vs-TP53-NonMutant
2.627600E-01
TP53-Mutant-vs-TP53-NonMutant
9.854800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
